MIR SCIENTIFIC

In News

Integrating miRNA profiling and machine learning for improved prostate cancer diagnosis - Nature

Nature - Aug 20, 2025

A drug that induces the microRNA miR-124 enables differentiation of retinoic acid–resistant neuroblastoma cells - Science | AAAS

Science | AAAS - Apr 15, 2025

miR Scientific announce the commercial availability of the miR Sentinel™ Prostate Cancer Test - BioPharma APAC

BioPharma APAC - Jul 14, 2022

Novel urine-based liquid biopsy launched in US prostate cancer market - Urology Times

Urology Times - Jul 19, 2022

Circ_0001671 regulates prostate cancer progression through miR-27b-3p/BLM axis - Nature

Nature - May 28, 2024

FDA grants breakthrough designation to urine-based liquid biopsy for prostate cancer - Urology Times

Urology Times - Oct 26, 2020

Secondary loss of miR-3607 reduced cortical progenitor amplification during rodent evolution - Science | AAAS

Science | AAAS - Jan 12, 2022

hsa-mir-483-3p modulates delayed breast cancer recurrence - Nature

Nature - Jan 03, 2025

The protective role of miR-223 in sepsis-induced mortality - Nature

Nature - Oct 19, 2020

Significance of miR-1290 in glioblastoma patients with epilepsy - Nature

Nature - Apr 22, 2025

Sinomenine attenuates uremia vascular calcification by miR-143-5p - Nature

Nature - Jan 13, 2025

miR-21 promotes cervical cancer by regulating NTF3 - Nature

Nature - Jan 19, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment